News About: R&D
YD Life Science acquires approval of DR therapy for Phase 2a clinical trial in U.S.
YD Life Science(CEO Jin-Woo Lee) announced on the 21st that its diabetic retinopathy(DR) therapy ‘YD-312’ acquired final approval for a Phase 2a clinical trial from the U.S. Food and Drug Administration.
Diabetic ret...
ProteomeTech acquires approval of IgE content diagnostic kit for first time in Korea
ProteomeTech(CEO Kook-Jin Lim) announced sales and manufacturing approval of the real-time monitoring of human IgE content ‘ImmuneCheck IgE’ from the Ministry of Food and Drug Safety on 8 August.
‘ImmuneCheck IgE,’ a...
Qurient acquires U.S. approval of Phase II clinical trial for MDR TB therapy Telacebec
Qurient(CEO Ki-Yeon Nam) announced a beginning of a Phase II clinical to globally develop a multi-drug resistant(MDR) tuberculosis(TB) therapy on the 17th of July.
Qurient said the company will start the Phase II cli...
"In order to raise chances, the number of clinical trials enter Phase II must be raised"
A position that a country takes in the new drug development field is decided based on the structure of clinical trials. While most clinical trials in the U.S. are on Phase I and Phase II, most Korean pharmaceutical co...
Korea put up a great fight in global downtrend with clinical studies
The number of clinical studies has decreased in the world, but Korea has had a slower decrease compared to other countries, showing a good sign.
According to the data that the National Institutes of Health(NIH) had i...
“In North Korea, selling profitable drugs is the main goal of studying pharmacology”
Despite researchers interested in and studying pharmacology even in North Korea, they eventually are led to developing profitable drugs for no purpose of study without any benefit from the government, to purchase food...
‘Artificial Intelligence’ over hypothesis-driven study
An opinion was raised that development of new drugs must go towards AI, not the conventional hypothesis-driven studies.
At the ‘Artificial Intelligence, New Paradigm of New Drug Development’ seminar on the 7th, Profe...
Hanmi Pharm’s new oral anticancer drug ‘Oraxol starts global Phase III clinical trial
They will actively start the global Phase III clinical trial of Oraxol, an oral anticancer drug developed by Hanmi Pharm.
A Hanmi Pharm’s partner, Athenex(Nasdaq: ATNX) announced that the company completed the Phase ...
Government to impose disciplinary fine for falsely reporting adverse drug reactions in clinical trials
If an institute or organization is exposed for a false report of adverse drug reactions during a clinical trial, a disciplinary fine will be imposed.
In order to keep patients participating in clinical trials safe an...
Curatis starts 2a clinical trial of adult tuberculosis vaccine this January
Curatis, an immune vaccine and immunotherapy company, announced to conduct a Phase 2a clinical trial of tuberculosis preventive vaccine for adults at Yonsei University Severance Hospital this January. The company acqu...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
March
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
23 | 24 | 25 | 26 | 27 | 28 | 1 |
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 | 1 | 2 | 3 | 4 | 5 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
